SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Summer Interns

IP-Watch interns talk about their Geneva experience in summer 2013. 2:42.

Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Latest Comments
  • So simply put, we have the NABP saying that all ph... »
  • The original Brustle decision was widely criticise... »

  • For IPW Subscribers

    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >


    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >

    IP-Watch Briefs

    01/04/2014: US Trade Barriers Report Highlights IPRs Among Top Concerns
    31/03/2014: UKIPO: New Exceptions In UK Copyright Law Boost Flexibility For Users
    31/03/2014: Korea Joins Hague Agreement; WIPO Hopes Others Will Follow
    24/03/2014: Analysis Shows Mixed Results On Big Pharma R&D Efforts For TB
    20/03/2014: UN Praises US Pullback Of Internet Control
    20/03/2014: Rise Of Knowledge Societies Leads To New Social Conflicts, Book Says
    18/03/2014: First Geneva Dialogue On Traditional Knowledge This Week
    17/03/2014: Breeders’ Group CIOPORA Redefining Its Position On IP
    12/03/2014: Book Challenges ‘Neoliberal’ Approach In Global Public Health Policy
    12/03/2014: WTO-WIPO IP Training Course For Governments
    11/03/2014: “Shame On You” – EU Parliament Pressured On Vote Over Surveillance
    10/03/2014: US To Hold Forum On Copyright Notice And Takedown System
    07/03/2014: Patents Not Best To Protect Traditional Medical Knowledge, Author Says
    07/03/2014: WHO Draft Guidelines On Sugars Intake
    07/03/2014: UN Campaign Engages Tourists In Fight Against Counterfeits
    05/03/2014: Intergovernmental South Centre Issues Statement On “US Attacks On Indian IP Policy”
    04/03/2014: Privatize, Don’t Internationalise, Internet Oversight, Academics Say
    03/03/2014: WHO Bulletin Article On Local Pharmaceutical Manufacturing In Africa
    26/02/2014: IP Rights Impact Practice Of Science, Global Justice, Author Says
    26/02/2014: US Congress Committee Issues Report On “Highly Invasive” FDA Surveillance Of Employees
    25/02/2014: US Calls On Brazil Internet Meeting To Stick To Principles
    24/02/2014: Infojustice: Graphics Show Rise In US Pharma Exports To India, Patent Grants By India
    20/02/2014: White House Announces Actions On Patents
    19/02/2014: European Parliament Key Vote On Net Neutrality Laws – 24 February
    18/02/2014: Infojustice.org: Australia Commits To Overhaul Of Copyright Act
    12/02/2014: WHO, IFRC Tap Swiss Federal Funds For New Buildings
    11/02/2014: DNDi Director: ‘Reality Check’ Needed For Neglected Diseases
    10/02/2014: Alert: Pharma IPR 2014 Conference In Mumbai, 26-28 February
    07/02/2014: EPO Appeals Board Upholds Ruling Limiting Stem Cell Patentability
    03/02/2014: African Union Backs WIPO DG Candidate Geoffrey Onyeama
    03/02/2014: “No Patents On Seeds” Serves EPO Patent Objection And Free Pepper Soup
    03/02/2014: WIPO Issues Tribute To Pete Seeger
    31/01/2014: MSF: AstraZeneca Pullout Of Neglected Disease R&D Proof System Broken
    29/01/2014: In State Of The Union, Obama Highlights Need For Patent Reform, Trade
    21/01/2014: EU Launches Consultation On Investor-State Dispute Mechanism In TTIP
    17/01/2014: New QUNO Reports Encourage Plant Variety Protection Alternatives
    16/01/2014: Successful WHO Drug Prequalification Programme Deemed At Risk
    13/01/2014: Event: The 6th Annual Corporate IP Counsel Forum
    09/01/2014: New EU Customs Enforcement Regulation On IPRs Takes Effect
    09/01/2014: New SIPO Commissioner Meets With Top WIPO Official From China
    08/01/2014: New Research Handbook On IP Licensing Available
    08/01/2014: Global Pharma, Biopharma Patent Laws In Spotlight At CPhI’s Pharma IPR Conference in India
    22/12/2013: WIPO To Hold Conference On Open Innovation
    22/12/2013: Conclusions From Top Trademark Offices Meeting
    20/12/2013: Report: Patents On Water Technology On The Rise
    20/12/2013: US Issues First Report On Russia’s WTO Implementation
    17/12/2013: US Intelligence Committee Chair To EU Parliament: NSA Necessary To Jointly Fight China
    17/12/2013: Swiss Group Finds Patent-Related Ethical Violations By Pharma Overseas
    16/12/2013: KIPO, SIPO Sign Cooperation Agreement Including IP Transactions
    12/12/2013: Medicines Patent Pool Strikes Deal With Bristol-Myers Squibb
    Your IP address is 54.205.188.59